XML 18 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Revenue:      
Royalties $ 289,594 $ 264,614 $ 262,415
Product revenue 36,509 26,052 17,321
Contract and other revenue 66,993 45,931 16,542
Total revenue 393,096 336,597 296,278
Operating costs and expenses:      
Cost of product revenue [1] 23,783 21,329 12,377
Cost of contract and other revenue 55,364 45,761 32,967
Research and development [1] 149,135 129,844 111,110
Sales, general and administrative [1] 110,940 95,145 70,554
Restructuring charges 0 0 3,576
Impairment of in-process research and development intangible asset 0 18,300 0
Change in contingent consideration liability 0 (6,845) 0
Gain from sale of intellectual property (533) 0 (3,686)
Gain from settlement 0 (579) (2,040)
Total operating costs and expenses 338,689 302,955 224,858
Operating income (loss) 54,407 33,642 71,420
Interest income (expense), net 1,384 1,740 1,224
Loss on Extinguishment of Debt (1,082) 0 0
Interest expense (13,720) (12,745) (12,413)
Interest and other income (expense), net (13,418) (11,005) (11,189)
Income before income taxes 40,989 22,637 60,231
Provision for (benefit from) income taxes 63,851 15,817 (151,157)
Net income (loss) $ (22,862) $ 6,820 $ 211,388
Net income (loss) per share:      
Basic (in dollars per share) $ (0.21) $ 0.06 $ 1.84
Diluted (in dollars per share) $ (0.21) $ 0.06 $ 1.80
Weighted average shares used in per share calculations:      
Basic (in shares) 110,198 110,162 114,814
Diluted (in shares) 110,198 113,140 117,484
[1] * Includes stock-based compensation: Cost of product revenue$78 $56 $63Research and development$12,185 $9,165 $6,762Sales, general and administrative$15,140 $11,792 $8,271